Belpointe Asset Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$2.26K	–	2760
2023 Q1	$2.26K	Hold	1,000	–	–	﹤0.01%	3278
2022 Q4	$3.49K	Buy	+1,000	New	+$3.49K	﹤0.01%	3060